Companies / Codiak BioSciences, Inc.
Codiak BioSciences, Inc.
CDAKCIK 1659352
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | ARCH Venture Fund VIII, L.P. 10% owner | Buy Open-market buy | Common Sotck | $7.50M | +5.0M +129.73% | 8,854,098 | high |
| Jun 8, 2021 | Sorensen Benny Executive | Sell Open-market sale | Common Stock | $176.3K | -7K -80.78% | 1,640 | medium |
| Jun 8, 2021 | Konstantinov Konstantin Executive | Sell Open-market sale | Common Stock | $160.1K | -6K -86.20% | 1,004 | medium |
| Feb 17, 2021 | Morrison Briggs Director | Buy Open-market buy | Common Stock | $100.0K | +5K | 4,761 | medium |
| Oct 13, 2020 | Melas Kyriazi Theo Director | Buy Open-market buy | Common Stock | $99.0K | +7K | 6,600 | medium |
| Jan 20, 2022 | Barna Nicole Executive | Buy Open-market buy | Common Stock | $50.0K | +7K | 6,781 | low |
| Jun 8, 2021 | Sorensen Benny Executive | Sell Open-market sale | Common Stock | $42.7K | -2K -100.00% | 0 | low |
| Jun 8, 2021 | Sorensen Benny Executive | Exercise Option exercise | Common Stock | $28.1K | +9K | 8,533 | low |